HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jean-Olivier Durand Selected Research

Mannose (D-Mannose)

7/2020The mannose 6-phosphate receptor targeted with porphyrin-based periodic mesoporous organosilica nanoparticles for rhabdomyosarcoma theranostics.
10/2019Porphyrin-based bridged silsesquioxane nanoparticles for targeted two-photon photodynamic therapy of zebrafish xenografted with human tumor.
6/2019Efficient Photodynamic Therapy of Prostate Cancer Cells through an Improved Targeting of the Cation-Independent Mannose 6-Phosphate Receptor.
2/2016Ruthenium(ii) complex-photosensitized multifunctionalized porous silicon nanoparticles for two-photon near-infrared light responsive imaging and photodynamic cancer therapy.
5/2015Mannose-6-phosphate receptor: a target for theranostics of prostate cancer.
12/2014Two-photon excitation of porphyrin-functionalized porous silicon nanoparticles for photodynamic therapy.
11/2011Mannose-functionalized mesoporous silica nanoparticles for efficient two-photon photodynamic therapy of solid tumors.
12/2010Silicalites and Mesoporous Silica Nanoparticles for photodynamic therapy.
3/2009Mannose-targeted mesoporous silica nanoparticles for photodynamic therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jean-Olivier Durand Research Topics

Disease

28Neoplasms (Cancer)
07/2020 - 07/2010
13Breast Neoplasms (Breast Cancer)
06/2021 - 03/2009
3Prostatic Neoplasms (Prostate Cancer)
06/2019 - 05/2015
2Phototoxic Dermatitis (Phototoxicity)
09/2019 - 12/2010
2Retinoblastoma (Glioblastoma, Retinal)
01/2018 - 08/2012
2Colorectal Neoplasms (Colorectal Cancer)
09/2012 - 02/2012
1Rhabdomyosarcoma
07/2020
1Hyperthermia
01/2019
1Atherosclerosis
11/2018
1Alzheimer Disease (Alzheimer's Disease)
11/2018
1Ovarian Neoplasms (Ovarian Cancer)
01/2018
1Skin Neoplasms (Skin Cancer)
01/2018
1Inflammation (Inflammations)
09/2017
1Lymphoma (Lymphomas)
05/2013
1Neuroblastoma
05/2013
1Glioblastoma (Glioblastoma Multiforme)
05/2013
1Rare Diseases (Rare Disease)
08/2012

Drug/Important Bio-Agent (IBA)

121-phenyl-3,3-dimethyltriazene (PDT)IBA
06/2021 - 03/2009
11Silicon Dioxide (Silica)FDA LinkGeneric
06/2019 - 07/2010
9Mannose (D-Mannose)IBA
07/2020 - 03/2009
8Pharmaceutical PreparationsIBA
01/2019 - 02/2012
5SiliconIBA
01/2017 - 05/2013
4PorphyrinsIBA
07/2020 - 05/2013
4Doxorubicin (Adriamycin)FDA LinkGeneric
01/2018 - 09/2014
4CamptothecinIBA
12/2013 - 02/2012
3LuciferasesIBA
06/2021 - 09/2019
3Small Interfering RNA (siRNA)IBA
06/2021 - 09/2019
2AT 760IBA
09/2019 - 09/2016
2CationsIBA
06/2019 - 05/2015
2Photosensitizing Agents (Photosensitizers)IBA
02/2016 - 02/2012
2GoldIBA
01/2016 - 01/2015
1PolymersIBA
07/2020
1Biological ProductsIBA
07/2020
1EthaneIBA
11/2019
1Peptides (Polypeptides)IBA
01/2019
1pepstatin (pepstatin A)IBA
01/2019
1Cathepsin DIBA
01/2019
1Peptide Hydrolases (Proteases)FDA Link
01/2019
1Singlet OxygenIBA
01/2018
1Nanoparticle Drug Delivery SystemIBA
01/2018
1Diclofenac (SR 38)FDA LinkGeneric
09/2017
1LipopolysaccharidesIBA
09/2017
1mannose-6-phosphateIBA
06/2016
1RutheniumIBA
02/2016
1Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric
02/2016
1LigandsIBA
02/2016
1DisulfidesIBA
08/2015
1LectinsIBA
05/2015
1IGF Type 2 Receptor (Insulin-Like-Growth-Factor II Receptor)IBA
05/2015
1Mannose ReceptorIBA
12/2014
1AntibodiesIBA
05/2013
1Rituximab (Mabthera)FDA Link
05/2013
1Hyaluronic Acid (Hyaluronan)IBA
09/2012
1CarbohydratesIBA
08/2012
1galactose receptorIBA
02/2012
1Galactose (Galactopyranose)FDA LinkGeneric
02/2012

Therapy/Procedure

15Photochemotherapy (Photodynamic Therapy)
06/2021 - 07/2010
12Therapeutics
01/2019 - 02/2012
6Precision Medicine
07/2020 - 05/2015
2Lasers (Laser)
10/2019 - 09/2016
1Nanospheres
01/2016